
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune systems ability to recognize and destroy diverse cancer cells in each patient. Our lead late-stage TIL product candidate, lifileucel for metastatic melanoma, has the potential to become the first approved one-time cell therapy for a solid tumor cancer. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited...
Immuno oncology,autologous cell therapy,tumor infiltrating lymphocytes (til),and novel cancer immunotherapies
Iovance biotherapeutics, inc operates in the Biotechnology research industry.
Iovance biotherapeutics, inc's HQ phone number is +16502607120
Iovance biotherapeutics, inc's revenue is 11m - 100m
Iovance biotherapeutics, inc has 501 - 1000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.